Report #2895225

Received May 4, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 60 yrs
State: FL
Recovered: Recovered
Vaccinated: Nov 25, 2025
Onset: Nov 25, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	2	946065	LA

Symptoms (2)

No adverse eventProduct preparation issue

Symptom narrative

Patient received HEPLISAV-B as second dose (after receiving Twinrix). Patient had requested Twinrix specifically. Patient did not report any side effects or adverse events.

Lab data

None